Therapeutic benefits of CD90‐negative cardiac stromal cells in rats with a 30‐day chronic infarct

Cardiac stromal cells (CSCs) can be derived from explant cultures, and a subgroup of these cells is viewed as cardiac mesenchymal stem cells due to their expression of CD90. Here, we sought to determine the therapeutic potential of CD90‐positive and CD90‐negative CSCs in a rat model of chronic myoca...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Deliang, Shen, Miaoda, Liang, Hongxia, Tang, Junnan, Wang, Bo, Liu, Chuang, Wang, Peiwen, Dong, Jianzeng, Li, Ling, Zhang, Jinying, Caranasos, Thomas G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824400/
https://www.ncbi.nlm.nih.gov/pubmed/29341439
http://dx.doi.org/10.1111/jcmm.13517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824400/
https://www.ncbi.nlm.nih.gov/pubmed/29341439
http://dx.doi.org/10.1111/jcmm.13517

Ejemplares similares